Literature DB >> 34138660

Outcome Comparison of Latissimus Dorsi Transfer and Pectoralis Major Transfer for Irreparable Subscapularis Tendon Tear: A Systematic Review.

Zhiwen Luo1, Jinrong Lin1, Yaying Sun1, Kesen Zhu1, Chenghui Wang1, Jiwu Chen1.   

Abstract

BACKGROUND: Latissimus dorsi transfer (LDT) and pectoralis major transfer (PMT) were developed to treat an irreparable subscapularis tendon tear (ISScT); however, the difference in their outcomes remains unclear.
PURPOSE: To systematically review and compare the outcomes of LDT and PMT for ISScT. STUDY
DESIGN: Systematic review; Level of evidence, 4.
METHODS: A systematic review was performed through a comprehensive search of Embase, PubMed, and the Cochrane Library. Studies of LDT or PMT were included according to the inclusion and exclusion criteria. The primary outcome was the Constant-Murley score (CMS) at the final follow-up. Secondary outcomes included the subjective shoulder value (SSV), visual analog scale (VAS) score for pain, active shoulder range of motion, and the belly-press and lift-off tests. Postoperative failure and complication rates were the safety outcome measures. Outcomes were summarized into the LDT and PMT groups, and results were compared statistically (P < .05).
RESULTS: Twelve studies were included in this review: 184 shoulders from 9 studies for the PMT group and 85 shoulders from 3 studies for the LDT group. For the PMT and LDT groups, the mean ages were 58.9 and 55.1 years, respectively, and the mean follow-up was 66.9 and 17.4 months, respectively. Overall, the LDT and PMT groups improved in the primary outcome (CMS) and secondary outcomes (SSV, VAS, ROM, and belly-press and lift-off tests), with low rates of failure and complication. When compared with the PMT group, the LDT group showed more significant improvements in CMS (35.2 vs 24.7; P < .001), active forward flexion (44.3° vs 14.7°; P < .001), abduction (35.0° vs 17.6°; P < .002), and positive belly-press test rate (45% vs 27%; P < .001). No statistically significant difference was seen between the groups in postoperative failure rate, complication rate, mean improvement of active internal rotation, VAS, or SSV.
CONCLUSION: In general, LDT showed significantly better clinical outcomes postoperatively than did PMT. The available fair-quality evidence suggested that LDT might be a better choice for ISScT. Further evaluations on the relative benefits of the 2 surgical approaches are required, with more high-quality randomized controlled studies.

Entities:  

Keywords:  irreparable subscapularis tendon tears; latissimus dorsi transfer; pectoralis major transfer; tendon transfer

Mesh:

Year:  2021        PMID: 34138660     DOI: 10.1177/03635465211018216

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  5 in total

1.  [Treatment of subscapularis tendon lesions].

Authors:  David Endell; Christopher Child; Florian Freislederer; Philipp Moroder; Markus Scheibel
Journal:  Unfallchirurgie (Heidelb)       Date:  2022-08-09

Review 2.  Current concepts review in the management of subscapularis tears.

Authors:  Girinivasan Chellamuthu; Shyam Sundar; David V Rajan
Journal:  J Clin Orthop Trauma       Date:  2022-04-12

3.  Relationship between the Hamada Grade and underlying pathological conditions in the rotator cuff and long head of biceps in symptomatic patients with rotator cuff tears.

Authors:  Akihiko Hasegawa; Teruhisa Mihata; Kunimoto Fukunishi; Akihiro Uchida; Masashi Neo
Journal:  JSES Int       Date:  2022-02-18

Review 4.  Comparing KTP and CO2 laser excision for recurrent respiratory papillomatosis: A systematic review.

Authors:  Jimin Yang; Zhongcheng Xie; Barnabas C Seyler
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-07-16

5.  Open Anterior Capsular Reconstruction With a Dermal Allograft Is a Viable Nonarthroplasty Salvage Procedure for Irreparable Subscapularis Tears at a Minimum 2-Year Follow-up.

Authors:  Simon Lee; Dylan R Rakowski; Marilee P Horan; Jared A Hanson; Justin J Ernat; Peter J Millett
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.